The Valley Desk

ArticleCrohn's & colitis 360Published

Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Crohn's & colitis 360
Published
Subject terms
Ulcerative colitis; Patient-reported Outcomes; Comparative Effectiveness Research; Vedolizumab; Tofacitinib
PubMed ID
37350775
PubMed Central ID
PMC10284045
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal